DE69739375D1 - Verfahren zur regulierung der stickstoffmonoxid-erzeugung - Google Patents

Verfahren zur regulierung der stickstoffmonoxid-erzeugung

Info

Publication number
DE69739375D1
DE69739375D1 DE69739375T DE69739375T DE69739375D1 DE 69739375 D1 DE69739375 D1 DE 69739375D1 DE 69739375 T DE69739375 T DE 69739375T DE 69739375 T DE69739375 T DE 69739375T DE 69739375 D1 DE69739375 D1 DE 69739375D1
Authority
DE
Germany
Prior art keywords
nitrogen monoxide
monoxide generation
regulating nitrogen
regulating
generation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69739375T
Other languages
English (en)
Inventor
Anthony B Troutt
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Immunex Corp
Original Assignee
Immunex Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=21978190&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE69739375(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Immunex Corp filed Critical Immunex Corp
Application granted granted Critical
Publication of DE69739375D1 publication Critical patent/DE69739375D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
    • C07K14/7155—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons for interleukins [IL]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Animal Behavior & Ethology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Toxicology (AREA)
  • Cell Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Compounds Of Alkaline-Earth Elements, Aluminum Or Rare-Earth Metals (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Separation By Low-Temperature Treatments (AREA)
  • Crystals, And After-Treatments Of Crystals (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
DE69739375T 1996-11-27 1997-11-21 Verfahren zur regulierung der stickstoffmonoxid-erzeugung Expired - Lifetime DE69739375D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US5252596P 1996-11-27 1996-11-27
PCT/US1997/021451 WO1998023284A1 (en) 1996-11-27 1997-11-21 Method of regulating nitric oxide production

Publications (1)

Publication Number Publication Date
DE69739375D1 true DE69739375D1 (de) 2009-06-04

Family

ID=21978190

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69739375T Expired - Lifetime DE69739375D1 (de) 1996-11-27 1997-11-21 Verfahren zur regulierung der stickstoffmonoxid-erzeugung

Country Status (8)

Country Link
US (1) US6083906A (de)
EP (1) EP0959897B1 (de)
JP (1) JP2001506982A (de)
AT (1) ATE429241T1 (de)
AU (1) AU7408998A (de)
DE (1) DE69739375D1 (de)
ES (1) ES2326347T3 (de)
WO (1) WO1998023284A1 (de)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993007863A1 (en) * 1991-10-15 1993-04-29 Mullarkey Michael F Methods and compositions for treating allergic reactions
EP0670730B1 (de) * 1992-03-30 2003-06-04 Immunex Corporation Fusionsprotein , das zwei rezeptoren des tumornekrose-faktors enthält
US6680057B1 (en) * 1995-03-23 2004-01-20 Immunex Corporation Methods of treating autoimmune disease by administering interleukin-17 receptor
PT817847E (pt) * 1995-03-23 2005-02-28 Immunex Corp Receptor de il-17
US6891082B2 (en) 1997-08-01 2005-05-10 The Johns Hopkins University School Of Medicine Transgenic non-human animals expressing a truncated activintype II receptor
US20050147609A1 (en) * 1998-05-15 2005-07-07 Genentech, Inc. Use of anti-IL-17 antibody for the treatment of cartilage damaged by osteoarthritis
US7067144B2 (en) * 1998-10-20 2006-06-27 Omeros Corporation Compositions and methods for systemic inhibition of cartilage degradation
EP1022027A1 (de) * 1999-01-22 2000-07-26 Applied Research Systems ARS Holding N.V. Antagonisten von Tumornecrosefaktor und ihre Verwendungen gegen Endometriose
WO2000064479A1 (en) * 1999-04-27 2000-11-02 Antibody Systems, Inc. Compositions containing tetracyclines for treating hemorrhagic virus infections and other disorders
MXPA03003407A (es) * 2000-10-18 2004-05-04 Immunex Corp Metodos para el tratamiento de artritis reumatoide usando antagonistas il-17.
US7708741B1 (en) 2001-08-28 2010-05-04 Marctec, Llc Method of preparing bones for knee replacement surgery
US7582670B2 (en) * 2001-12-13 2009-09-01 Natrogen Therapeutics, Inc. Methods of treating an inflammatory-related disease
US20050154046A1 (en) * 2004-01-12 2005-07-14 Longgui Wang Methods of treating an inflammatory-related disease
US8563525B2 (en) 2004-01-12 2013-10-22 Natrogen Therapeutics International, Inc. Methods of treating an inflammatory-related disease
PL376536A1 (pl) * 2002-08-28 2006-01-09 Immunex Corporation Kompozycje i sposoby leczenia chorób układu sercowo-naczyniowego
WO2004028548A2 (en) * 2002-09-26 2004-04-08 Carbomer, Inc. Inhibitors of the nitrix oxide synthase iii (nos iii) as neuroprotective agents
GB0417487D0 (en) 2004-08-05 2004-09-08 Novartis Ag Organic compound
US7767206B2 (en) * 2006-10-02 2010-08-03 Amgen Inc. Neutralizing determinants of IL-17 Receptor A and antibodies that bind thereto
CN101426268B (zh) * 2007-11-02 2010-08-25 大唐移动通信设备有限公司 导频资源分配方法、系统和设备
NZ600584A (en) * 2008-05-05 2014-05-30 Novimmune Sa Anti-il 17a/il-17f cross-reactive antibodies and methods of use thereof
US20100233270A1 (en) 2009-01-08 2010-09-16 Northwestern University Delivery of Oligonucleotide-Functionalized Nanoparticles
MX2011011729A (es) 2009-05-05 2012-04-10 Novimmune Sa Anticuerpo anti il-17f y metodos de uso de los mismos.
RS59743B1 (sr) 2010-01-15 2020-02-28 Kirin Amgen Inc Formulacija antitela protiv il-17ra i terapeutski režimi za lečenje psorijaze
CA3023451A1 (en) 2016-05-06 2017-11-09 Exicure, Inc. Liposomal spherical nucleic acid (sna) constructs presenting antisense oligonucleotides (aso) for specific knockdown of interleukin 17 receptor mrna
WO2018201090A1 (en) 2017-04-28 2018-11-01 Exicure, Inc. Synthesis of spherical nucleic acids using lipophilic moieties

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5230742A (en) 1987-02-02 1993-07-27 A. E. Staley Manufacturing Co. Integrated process for producing crystalline fructose and high-fructose, liquid-phase sweetener
US5319071A (en) 1987-11-25 1994-06-07 Immunex Corporation Soluble interleukin-1 receptors
WO1989004838A1 (en) 1987-11-25 1989-06-01 Immunex Corporation Interleukin-1 receptors
US6541610B1 (en) 1989-09-05 2003-04-01 Immunex Corporation Fusion proteins comprising tumor necrosis factor receptor
US5395760A (en) 1989-09-05 1995-03-07 Immunex Corporation DNA encoding tumor necrosis factor-α and -β receptors
US5416013A (en) 1990-04-04 1995-05-16 Sterling Winthrop Inc. Interleukin 1β protease and interleukin 1β protease inhibitors
US5464938A (en) 1990-04-09 1995-11-07 Immunex Corporation Isolated viral protein TNF antagonists
US5350683A (en) 1990-06-05 1994-09-27 Immunex Corporation DNA encoding type II interleukin-1 receptors
US5359039A (en) 1993-07-09 1994-10-25 Immunex Corporation Isolated poxvirus A53R-equivalent tumor necrosis factor antagonists
US5594106A (en) 1993-08-23 1997-01-14 Immunex Corporation Inhibitors of TNF-α secretion
PT817847E (pt) 1995-03-23 2005-02-28 Immunex Corp Receptor de il-17
US5744340A (en) * 1995-06-09 1998-04-28 Schering Corporation Expression of human inducible nitric oxide synthase

Also Published As

Publication number Publication date
US6083906A (en) 2000-07-04
WO1998023284A1 (en) 1998-06-04
EP0959897A1 (de) 1999-12-01
JP2001506982A (ja) 2001-05-29
EP0959897B1 (de) 2009-04-22
ES2326347T3 (es) 2009-10-07
AU7408998A (en) 1998-06-22
EP0959897A4 (de) 2002-01-30
ATE429241T1 (de) 2009-05-15

Similar Documents

Publication Publication Date Title
ATE429241T1 (de) Verfahren zur regulierung der stickstoffmonoxid- erzeugung
TR199802676A2 (xx) T�m�rlerin, t�m�rle ilgili hastal�klar�n ve ka�eksinin tedavisi ve �nlenmesi i�in y�ntem.
DE69703547D1 (de) Dauerhafte, niedrige oberflächenenergie aufweisende verbindungen und gegenstände, vorrichtungen und verfahren zur verwendung davon
NO20001583D0 (no) Stimulering av hematopoetiske celler in vitro
ATE420432T1 (de) Verfahren und vorrichtung zur prädiktiven quantisierung von stimmhaften sprachsignalen
IL151149A0 (en) Zinc finger domains and methods of identifying same
ATE290375T1 (de) Verwendung eines mittels zur verminderung des risikos kardiovaskulärer erkrankungen
DE69941744D1 (de) Verfahren zur Reduzierung des Metallgehalts in fluorhaltigem Polymer
DE3871711D1 (de) Verfahren und geraet zur verbesserung der verstaendlichkeit von stimmen in hoher geraeuschumgebung.
DE69839039D1 (de) Vorrichtung und verfahren zur skalierung und flickerreduktion mit dynamischer koeffizientengewichtung
TR200100056T2 (tr) Nörotrofik faktörler
DE69733710D1 (de) Informationsverarbeitungsgerät und -verfahren, sowie Speichermedium zur Speicherung des auszuführenden Verfahrens
DE60107416D1 (de) Adnf mischungen zur verbesserung der lernfähigkeit und der gedächtnisfunktion
DE69823562D1 (de) Initiatorsystem sowie damit hergestellte polymerisierbare zusammensetzungen
HUP0101667A3 (en) Method of determining the optimal erase and write power, and recording apparatus with devices for said methods
DE59807318D1 (de) Vorrichtung sowie Verfahren zur schnellen Bereitstellung von Leistungsreserven bei kombinierten Gas- und Dampfturbinenanlagen
DE69901076D1 (de) Lineares Trien sowie Copolymer davon
DE60332029D1 (de) Screening-verfahren für kognitive erweiterungsvorrichtungen
DE60334499D1 (de) Verfahren zur erhöhung der ausbreitung von b-zellen
DK0821588T3 (da) Levobupivacain og anvendelse heraf som et anæstetikum til gravide kvinder
NO980051D0 (no) Fremgangsmåte for å bestemme formasjoners hydrokarbon-metning og hydrokarbon-opphold i borehull, utfra multidetektor karbonoksygen-målinger
DE602004005158D1 (de) Oberflächenschichtsaffinitätschromatographie
DE68909000D1 (de) Kornorientierte Siliziumstahlbleche mit niedrigen Wattverlusten und Verfahren zur Herstellung derselben.
ATE543429T1 (de) Verfahren zur bestimmung des sympathikus-tonus und messsystem dafür
AU2001256868A1 (en) Device and method for electrochemically generating one or more gases

Legal Events

Date Code Title Description
8363 Opposition against the patent